| Name |
Recombinant Human LILRA6/CD85b/ILT8 Protein, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9088-T4
|
| Category |
Protein
|
| Prices |
$429.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
Human embryonic kidney cell, HEK293-derived Gly24-Asn447, with a C-terminal 6-His tag
|
| Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its binding ability in a functional ELISA. When Recombinant Human LILRA6/CD85b/ILT8 is coated onto a microplate at 2 μg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 (Catalog # 914-AN ) binds with a typical ED 50 = 0.1-0.6 μg/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
Q6PI73
|
| Gene |
LILRA6
|
| Sequence |
Gly24
|
| Supplier Page |
Shop
|
When Recombinant Human LILRA6/CD85b/ILT8 is coated onto a microplate at 2 µg/mL, Recombinant Human Angiopoietin-like Protein 7 (Catalog # 914-AN ) binds with a typical ED 50 of 0.1-0.6 µg/mL.